Gastrointestinal cancer
Showing 9976 - 10000 of >10,000
Refractory Prostate Carcinoma Trial (Biopsy, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Refractory Prostate Carcinoma
- Biopsy
- +6 more
- (no location specified)
Apr 25, 2023
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (Bortezomib, Dexamethasone, Pelareorep)
Not yet recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Los Angeles, California
- +1 more
Aug 19, 2022
Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)
Active, not recruiting
- Metastatic Prostate Cancer
- Ipatasertib
- +3 more
-
Chandler, Arizona
- +183 more
Nov 24, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Acceptability, Appropriateness, and Feasibility/Usability
Not yet recruiting
- Metastatic Breast Cancer
- End of Life
- Clinician Qualitative Interview
-
Chapel Hill, North CarolinaUniversity of North Carolina
Jun 27, 2022
Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States
Active, not recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +2 more
- Atezolizumab
- +3 more
-
New York, New York
- +4 more
Jul 16, 2022
2D and 3D Primary Cell Cultures From Gastric and
Not yet recruiting
- Gastric and Gastroesophageal Junction Cancer
-
Berlin, GermanyDepartment of Anesthesiology and Operative Intensive Care Medici
Sep 13, 2022
Esophageal Cancer Associated Neoantigens
Not yet recruiting
- Esophageal Cancer
- Neoantigen
- ratio of predicted neoantigens
-
Ho Chi Minh City, VietnamUniversity Medical Center Ho Chi Minh City
Aug 9, 2022
Hematological Disorder Trial in Chapel Hill (Focus Group Discussions and Semi-structured Interviews, Training community lay
Not yet recruiting
- Hematological Disorder
- Focus Group Discussions and Semi-structured Interviews
- Training community lay navigators
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center, UNC
Apr 12, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Devimistat
- Modified FOLFIRINOX
-
Ann Arbor, MichiganRogel Cancer Center
Jun 26, 2023
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
Increased Lymph Node Yield in Colorectal Cancer Synchronous
Completed
- Colorectal Cancer Stage IV
- Lymph Node Yield
- lymph node yield
-
Harbin, Heilongjiang, ChinaEthics and ethics of the Second Affiliated Hospital of Harbin Me
Dec 19, 2022
Persistent Atrial Fibrillation Trial in United Kingdom, United States (AtriCure EPi-Sense-AF Guided Coagulation System with
Active, not recruiting
- Persistent Atrial Fibrillation
- AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax
- Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering
-
Birmingham, Alabama
- +26 more
Jun 20, 2022
NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)
Completed
- Non-small Cell Lung Cancer
- +9 more
- PF-06946860
- Placebo for PF-06946860
-
Little Rock, Arkansas
- +32 more
Dec 12, 2022
Cigarette Smoking Trial in Vientiane (Nicotine patch, Self-help materials (to support smoking cessation), Smartphone-based
Recruiting
- Cigarette Smoking
- Nicotine patch
- +2 more
-
Vientiane, Lao People's Democratic Republic
- +1 more
Jun 17, 2022
Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)
Recruiting
- Gastric or Gastroesophageal Junction Adenocarcinoma
- PD-1 inhibitor
-
Guangzhou, ChinaSun Yat-sen University Cancer Center
Aug 9, 2023
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- SIGNATERA™ ctDNA testing
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 26, 2022
NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Telisotuzumab Vedotin
- +4 more
- (no location specified)
Oct 17, 2023
Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States
Withdrawn
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Abemaciclib
- Trastuzumab Emtansine
-
Yuma, Arizona
- +5 more
May 25, 2022
Lung Cancer Trial (bronchoscope)
Not yet recruiting
- Lung Cancer
- bronchoscope
- (no location specified)
Aug 8, 2023
Response to Anti-Cancer Therapy
Recruiting
- Carcinomas (Including Squamous Cell and Adenocarcinoma)
- Neoplasms
- blood draw
-
Stanford, CaliforniaStanford University School of Medicine
Mar 15, 2022
FTT PET/CT in Metastatic Prostate Cancer
Not yet recruiting
- Prostate Cancer Metastatic
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jul 13, 2022
Breast Cancer Trial in Houston, San Juan (Baseline Fitness Test, Questionnaires, Individualized Exercise Program)
Active, not recruiting
- Breast Cancer
- Baseline Fitness Test
- +3 more
-
Houston, Texas
- +1 more
Oct 11, 2022